ocrelizumab
cibisatamab
reagin
idiospecific
-lim-
Forssman antibody
panitumumab
-ab
heterophil antibody
heterophile antibody
conatumumab
atezolizumab
evolocumab
drozitumab
immunospecific
oleclumab
immunoprobe
siltuximab
biciromab
bezlotoxumab
robatumumab
alloantibody
sulesomab
zolimomab
heterophile
olendalizumab
bococizumab
onartuzumab
Ab
-a-
monoclonal
dacetuzumab
antiantibody
pancytokeratin
antigenic
iratumumab
antigenomic
lintuzumab
tabalumab
inotuzumab ozogamicin
agonistic monoclonal antibody
countercorrelated
matuzumab
antisynthetase
intrabody
ABO antibodies
immunonaive
polyantibody
-i-
brentuximab